Flying Brands inks cirrhosis biomarker deal with University of Alabama

(Sharecast News) - Flying Brands has been awarded a development contract by the University of Alabama to develop a biomarker derived from routine computed tomographic images.UAB will pay Imaging Biometrics, a wholly-owned subsidiary of Flying Brands, a fee to develop its software product aimed at quantifying liver surface nodularity, which allows prediction of cirrhosis decompensation and death, as well as an additional fee for regulatory services.Both Flying Brands and Imaging Biometrics were seeking to translate findings from a 2016 paper on Radiology into a "commercially robust software product" that will streamline the CT scan process, allowing for a quicker and more efficient method of determining how well patients respond to treatment.Imaging Biometrics' chief executive David Smith, said: "We believe this agreement could generate significant revenues for Imaging Biometrics.""UAB's decision to enlist Imaging Biometrics as a development partner underscores their confidence in Imaging Biometrics' proven track record of commercialising advanced imaging technologies into routine clinical applications."As of 0815 BST, Flying Brands shares had picked up 2.24% to 2.15p.